ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.
Mol Cancer. 2020 Aug 10;19(1):123. doi: 10.1186/s12943-020-01239-w.
Mol Cancer. 2020.
PMID: 32772918
Free PMC article.